EMPI
BMRN icon

Elo Mutual Pension Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History

Elo Mutual Pension Insurance’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32M Sell
23,025
-13,741
-37% -$753K 0.02% 470
2026
Q1 		$2.08M Sell
36,766
-5,041
-12% -$294K 0.03% 358
2025
Q4 		$2.48M Sell
41,807
-4,573
-10% -$249K 0.04% 327
2025
Q3 		$2.51M Buy
46,380
+22,851
+97% +$1.31M 0.04% 318
2025
Q2 		$1.29M Sell
23,529
-50
-0.2% -$2.94K 0.03% 391
2025
Q1 		$1.67M Buy
23,579
+4,510
+24% +$303K 0.04% 342
2024
Q4 		$1.25M Buy
19,069
+2,203
+13% +$148K 0.03% 427
2024
Q3 		$1.19M Sell
16,866
-17
-0.1% -$1.42K 0.03% 410
2024
Q2 		$1.39M Sell
16,883
-236
-1% -$19.6K 0.03% 360
2024
Q1 		$1.5M Buy
17,119
+690
+4% +$61.8K 0.04% 356
2023
Q4 		$1.58M Buy
16,429
+719
+5% +$63.6K 0.04% 332
2023
Q3 		$1.39M Buy
15,710
+624
+4% +$55.5K 0.04% 321
2023
Q2 		$1.31M Buy
15,086
+3,338
+28% +$314K 0.04% 342
2023
Q1 		$1.14M Sell
11,748
-2,570
-18% -$266K 0.04% 339
2022
Q4 		$1.48M Buy
14,318
+424
+3% +$39.8K 0.05% 303
2022
Q3 		$1.18M Sell
13,894
-612
-4% -$54.5K 0.04% 315
2022
Q2 		$1.2M Buy
14,506
+67
+0.5% +$5.33K 0.04% 329
2022
Q1 		$1.11M Buy
14,439
+561
+4% +$46.9K 0.03% 411
2021
Q4 		$1.23M Buy
13,878
+992
+8% +$81.9K 0.03% 360
2021
Q3 		$996K Hold
12,886
– – 0.03% 347
2021
Q2 		$1.07M Sell
12,886
-211
-2% -$16.7K 0.04% 345
2021
Q1 		$989K Buy
13,097
+203
+2% +$16.6K 0.03% 351
2020
Q4 		$1.13M Buy
+12,894
New +$1.02M 0.04% 316

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Elo Mutual Pension Insurance's BMRN Position: Q2 2026 in Review

Elo Mutual Pension Insurance reduced its BioMarin Pharmaceuticals (BMRN) stake by 37% in Q2 2026, selling an estimated $753K and leaving 23,025 shares worth $1.32M. The position accounts for 0.02% of the portfolio, ranked #470.

Elo Mutual Pension Insurance first reported a position in BMRN in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.51M in Q3 2025. 564 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Elo Mutual Pension Insurance held 23,025 shares of BioMarin Pharmaceuticals worth $1.32M as of Q2 2026.
  • Elo Mutual Pension Insurance sold 13,741 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $753K.
  • BioMarin Pharmaceuticals made up 0.02% of Elo Mutual Pension Insurance's portfolio in Q2 2026, its #470 holding.
  • Elo Mutual Pension Insurance first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • Elo Mutual Pension Insurance's BioMarin Pharmaceuticals position peaked at $2.51M in Q3 2025.
  • 564 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Elo Mutual Pension Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.